Clinical Trial Update: The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on the safety and efficacy of iSCLife-ACI human umbilical cord mesenchymal stem cells for acute cerebral infarction, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• iSCLife®-ACI (mesenchymal stem cells)

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Cerebral Infarction | Phase 1 | Status: SUSPENDED